TM Bioscience signs distribution agreement with Gamidor in Israel

01-Dec-2004

TM Bioscience Corporation, an emerging leader in the commercial genetic testing market, has signed a distribution agreement with Gamidor diagnostics (Petach Tikva, Israel), a leading distributor of clinical diagnostics in Israel. Under the agreement, Gamidor will have exclusive rights to distribute the Tag-It(TM) menu of genetic tests in Israel for a minimum three-year term that can be extended annually. As Tm launches new products, they can be rolled in to the agreement upon approval of both parties.

"Gamidor, like Tm, is committed to providing its customers with the most advanced and accurate diagnostic technology available," said Greg Hines, President and CEO of Tm Bioscience. "They are the ideal partners to enable Tm to penetrate a major market for our products beyond North America." Gamidor distributes products in Israel for the world's largest suppliers of clinical diagnostics, including Perkin Elmer Life Sciences and Dade Behring.

"The market for genetic tests is well established in Israel and we anticipate tests from Tm, in particular their Cystic Fibrosis gene test and Ashkenazi Jewish Panel, will be well received," said Yacob Ofer, CEO of Gamidor Diagnostics. "These will be important products to showcase Gamidor's leadership role as a provider of cutting edge diagnostic products."

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures